Back to all news

FDA Clears AIRS Medical AI for Rapid MRI Body Composition Analysis

FDA Clears AIRS Medical AI for Rapid MRI Body Composition Analysis

AIRS Medical's SwiftSight Body Composition AI software receives FDA 510(k) clearance for automated MRI-based body composition reporting.

Key Details

  • 1SwiftSight Body Composition is an AI tool to quantify muscle and fat from MRI scans.
  • 2FDA 510(k) clearance enables clinical deployment in the U.S.
  • 3The software enables body composition assessments from scans in under five minutes, with automated AI analysis and reporting.
  • 4Designed for use with existing MRI systems and workflow integration, aiding high-volume imaging operations.
  • 5First U.S. deployment will be with radiology provider SimonMed Imaging.
  • 6AIRS Medical recently received private equity funding from TA Associates.

Why It Matters

This clearance marks an advance in quantitative, repeatable body composition metrics in clinical MRI workflows, supporting preventative and wellness programs. Scalable, fast AI-driven analyses could expand indications for MRI and offer new operational and business models for imaging centers.
Radiology Business

Source

Radiology Business

View all from this source

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.